The store will not work correctly when cookies are disabled.
N-methyl-N-[4-oxo-3-[1-(2,2,3,3,3-pentafluoropropyl)pyrazol-4-yl]-2-(trifluoromethyl)pyrido[1,2-a]pyrimidin-8-yl]carbamoyl fluoride
ID: ALA4874614
PubChem CID: 156409474
Max Phase: Preclinical
Molecular Formula: C17H10F9N5O2
Molecular Weight: 487.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C(=O)F)c1ccn2c(=O)c(-c3cnn(CC(F)(F)C(F)(F)F)c3)c(C(F)(F)F)nc2c1
Standard InChI: InChI=1S/C17H10F9N5O2/c1-29(14(18)33)9-2-3-31-10(4-9)28-12(16(21,22)23)11(13(31)32)8-5-27-30(6-8)7-15(19,20)17(24,25)26/h2-6H,7H2,1H3
Standard InChI Key: UFCNUSBTDRVBSM-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
7.5322 -6.6779 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1277 -7.3877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9447 -7.3831 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5934 -6.1619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5923 -6.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3003 -7.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2985 -5.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0071 -6.1583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0060 -6.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7122 -7.3880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4240 -6.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4252 -6.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7145 -5.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7145 -4.9295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1283 -8.2087 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.8842 -7.3895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1768 -6.9803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8836 -8.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1755 -8.6147 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5910 -8.6158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1318 -5.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8776 -6.0866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4258 -5.4806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0189 -4.7719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2192 -4.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3531 -4.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1660 -3.9426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5001 -3.1968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3130 -3.1133 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.7043 -2.9799 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.2821 -2.4020 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.3729 -4.7298 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.9507 -4.1520 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 6 2 0
6 9 1 0
8 7 1 0
7 4 2 0
8 9 1 0
8 13 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
11 2 1 0
2 15 1 0
5 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
18 20 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 21 2 0
12 21 1 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
28 30 1 0
28 31 1 0
27 32 1 0
27 33 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 487.28 | Molecular Weight (Monoisotopic): 487.0691 | AlogP: 4.30 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.50 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.41 | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.31 | Np Likeness Score: -1.23 |
References
1. Sabnis RW.. (2021) Novel Heterocyclic Compounds as Delta-5-Desaturase Inhibitors for Treating Metabolic and Cardiovascular Diseases., 12 (8.0): [PMID:34413950] [10.1021/acsmedchemlett.1c00394] |